Benchmark analyst Bruce Jackson initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $57.
Why Is Dental Supplier Henry Schein Stock Trading Higher Today?
Henry Schein Inc (NASDAQ: HSIC) reported Q3 FY23 sales of $3.16 billion, slightly missing the